日本語 
Biotech
Japan medical manufacturing firm Nissha Co. Ltd. is building upon its worldwide healthcare technology presence through a significant United States micro molding initiative. Its division, Nissha Medical Technologies recently invested…
Daiichi Sankyo Acquires Anti-TA-MUC1 Antibody IP from Glycotope
Daiichi Sankyo Company, Ltd announced that it will pay Glycotope $132.5 million…
Daiichi Sankyo Acquires Anti-TA-MUC1 Antibody IP from Glycotope
Daiichi Sankyo Company, Ltd announced that it will pay Glycotope $132.5 million…
English